ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0276

Exploring the Prevalence of Crowned Dens Syndrome in a Polymyalgia Rheumatica Veterans Affairs Patient Cohort

Marlene Marte Furment1, Binod Kc1, Bhavya Poudyal1, Aakritee Sharma Subedi2, Mahnoor Sherazi3, Jihad Ben Gabr1, Shveta Trikha4, Brian Cooney5 and Fatme Allam5, 1SUNY Upstate Medical University, Syracuse, NY, 2SUNY Upstate University Hospital, Syracuse, 3State University of New York, Syracuse, NY, 4Syracuse VA Medical Center, Syracuse, 5Syracuse VA Medical Center, Syracuse, NY

Meeting: ACR Convergence 2024

Keywords: Computed tomography (CT), Crystal-induced arthritis, Polymyalgia Rheumatica (PMR), pseudogout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Crowned Dens (CD) is the radiological finding of calcium pyrophosphate dihydrate (CPPD) crystal deposition in the cruciform and alar ligaments giving the appearance of a crown surrounding the dens. When these imaging findings are associated with recurrent shoulder girdle stiffness and pain, fever and/or elevation of acute phase reactants, it is Crowned Dens Syndrome (CDS). Clinical presentation is similar to Polymyalgia Rheumatica (PMR), however CDS clinical course and management are different. We hypothesize that CDS is misdiagnosed as PMR in some cases. This study was performed as a quality improvement project to promote early recognition of CDS.

Methods: This study was based on a retrospective analysis of electronic medical records of 501 charts at the Syracuse VA Medical Center between 08/2018 and 08/2023. Available CT Head and/or Neck were reviewed with attending radiologists looking for evidence of calcification around the dens (Figure 1). Data was collected by chart review including age, gender, history of peripheral CPPD, prior diagnosis of PMR, cervical/shoulder pain or stiffness, hip girdle pain, ESR and CRP. Additionally, PTH, calcium, vitamin D, phosphorus, magnesium, ferritin, alkaline phosphatase values were collected to rule out secondary causes of CPPD. We also collected treatment modality with NSAIDs, glucocorticoids or DMARDs. Additionally, we analyzed a total 186 patients with peripheral CPPD without history of neck pain. Statistical analysis was performed calculating Fisher’s Exact Test p-value.

Results: 315 total charts of patients diagnosed with Polymyalgia Rheumatica were reviewed. 195 had accessible charts out of which 69 had available CT Head and/or Neck done for other indications. 19 of the 69 patients had imaging and clinical findings consistent with Crowned Dens Syndrome (27.54%). Median age was 78 and 18/19 were males. All 19 patients had symptomatic peripheral CPPD at different intervals. 17/19 had elevated ESR (89.47%) and 15/19 had elevated CRP (78.94%). Only one patient had fever on presentation and 2/19 had associated hypothyroidism. All patients were treated with variable doses of glucocorticoids for at least 6 months. On the other hand, out of all patients with peripheral CPPD without neck pain, CT Scan Head and/or Neck were available on 81 patients. 65/81 had evidence of crowned dens (80.2%) without symptoms of neck pain or stiffness.

Conclusion: Our study indicates that CPPD deposition frequently involves the dens on patients with established peripheral CPPD in approximately 84% of the cases (p-value < 0.0001; table 1). Our data suggests that a sizable percentage (approximately 22%) of these patients have symptomatic Crowned Dens Syndrome that was misdiagnosed as PMR. Clinicians should recognize this important differential diagnosis to avoid unnecessary tests and treatment, especially on patients with established CPPD.

Supporting image 1

Figure 1. Axial (Figure 1.A), sagittal (Figure 1.B) and coronal (Figure 1.C) views on CT of the Cervical Spine showing calcification around the dens consistent with Crowned Dens.

Supporting image 2

Table 1. Comparison of Crowned Dens radiological findings in patients with peripheral CPPD versus patients without peripheral CPPD.


Disclosures: M. Marte Furment: None; B. Kc: None; B. Poudyal: None; A. Sharma Subedi: None; M. Sherazi: None; J. Ben Gabr: None; S. Trikha: None; B. Cooney: None; F. Allam: None.

To cite this abstract in AMA style:

Marte Furment M, Kc B, Poudyal B, Sharma Subedi A, Sherazi M, Ben Gabr J, Trikha S, Cooney B, Allam F. Exploring the Prevalence of Crowned Dens Syndrome in a Polymyalgia Rheumatica Veterans Affairs Patient Cohort [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/exploring-the-prevalence-of-crowned-dens-syndrome-in-a-polymyalgia-rheumatica-veterans-affairs-patient-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-the-prevalence-of-crowned-dens-syndrome-in-a-polymyalgia-rheumatica-veterans-affairs-patient-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology